{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T14:22:25Z","timestamp":1768659745300,"version":"3.49.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.2169\/internalmedicine.5811-25","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:08:47Z","timestamp":1751479727000},"page":"297-302","source":"Crossref","is-referenced-by-count":0,"title":["Coronavirus Disease 2019-associated Minimal Change Disease: Transient Improvement Does Not Preclude the Need for Standard Therapy in a Case Report and Review of the Literature"],"prefix":"10.2169","volume":"65","author":[{"given":"Ryosuke","family":"Saiki","sequence":"first","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enyo","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol 12: 332-345, 2017.","DOI":"10.2215\/CJN.05000516"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Glassock RJ. Secondary minimal change disease. Nephrol Dial Transplant 18 (Suppl 6): vi52-vi58, 2003.","DOI":"10.1093\/ndt\/gfg1060"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tamura H, Kuraoka S, Hidaka Y, Nagata H, Furuie K, Nakazato H. A case of nephrotic syndrome that resolved with influenza B infection. Case Rep Nephrol Dial 11: 103-109, 2021.","DOI":"10.1159\/000515062"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Haruki A, Ishikawa E, Katayama K, et al. Spontaneous remission of adult-onset minimal change nephrotic syndrome associated with influenza B infection: a case report. BMC Nephrol 19: 162, 2018.","DOI":"10.1186\/s12882-018-0961-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kudose S, Batal I, Santoriello D, et al. Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol 31: 1959-1968, 2020.","DOI":"10.1681\/ASN.2020060802"},{"key":"6","unstructured":"6. May RM, Cassol C, Hannoudi A, et al. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19). Kidney Int 100: 1303-1315, 2021."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gupta RK, Bhargava R, Shaukat AA, Albert E, Leggat J. Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases. BMC Nephrol 21: 326, 2020.","DOI":"10.1186\/s12882-020-01970-y"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Alvarado A, Franceschi G, Resplandor E, Sumba J, Orta N. COVID-19 associated with onset nephrotic syndrome in a pediatric patient: coincidence or related conditions? Pediatr Nephrol 36: 205-207, 2021.","DOI":"10.1007\/s00467-020-04724-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Akyol AK, Din\u00e7 GA, Mustafao\u011flu \u00d6, Yah\u015fi A, Bayhan G\u0130, \u00d6zl\u00fc SG. Spontaneous remission of nephrotic syndrome associated with COVID-19 infection in an 8-year-old boy. Turk J Pediatr 64: 1117-1121, 2022.","DOI":"10.24953\/turkjped.2021.4559"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Enya T, Morimoto Y, Oshima R, et al. Nephrotic syndrome relapse in a boy with COVID-19. CEN Case Rep 10: 431-434, 2021.","DOI":"10.1007\/s13730-021-00587-w"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Morgan KM, Imani PD. Case report: a 5-year-old with new onset nephrotic syndrome in the setting of COVID-19 infection. BMC Nephrol 22: 323, 2021.","DOI":"10.1186\/s12882-021-02520-w"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shah SA, Carter HP. New-onset nephrotic syndrome in a child associated with COVID-19 infection. Front Pediatr 8: 471, 2020.","DOI":"10.3389\/fped.2020.00471"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tang S, Lai FMM, Lui YH, et al. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 68: 1750-1758, 2005.","DOI":"10.1111\/j.1523-1755.2005.00591.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yamada M, Rastogi P, Ince D, et al. Minimal change disease with nephrotic syndrome associated with coronavirus disease 2019 after apolipoprotein L1 risk variant kidney transplant: a case report. Transplant Proc 52: 2693-2697, 2020.","DOI":"10.1016\/j.transproceed.2020.08.012"},{"key":"15","unstructured":"15. Pasilan RMF, Manalili SAR, Villanueva ART. Minimal change disease associated with SARS-CoV-2 (COVID-19) infection among adult Filipinos: a report of two cases and review of related literature. Acta Med Philipp 58: 62-67, 2024."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kim HW, Kim EH, Roh YH, et al. Glomerulonephritis following COVID-19 infection or vaccination: a multicenter study in South Korea. Kidney Res Clin Pract 43: 165-176, 2024.","DOI":"10.23876\/j.krcp.23.219"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nomura E, Finn LS, Bauer A, et al. Pathology findings in pediatric patients with COVID-19 and kidney dysfunction. Pediatr Nephrol 37: 2375-2381, 2022.","DOI":"10.1007\/s00467-022-05457-w"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sethi S, Fervenza FC, Zhang Y, et al. Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83: 293-299, 2013.","DOI":"10.1038\/ki.2012.384"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Oda T, Yoshizawa N. Factors affecting the progression of infection-related glomerulonephritis to chronic kidney disease. Int J Mol Sci 22: 905, 2021.","DOI":"10.3390\/ijms22020905"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney Int 100: 753-779, 2021.","DOI":"10.1016\/j.kint.2021.05.015"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vivarelli M, Moscaritolo E, Tsalkidis A, Massella L, Emma F. Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome. J Pediatr 156: 965-971, 2010.","DOI":"10.1016\/j.jpeds.2009.12.020"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sureshkumar P, Hodson EM, Willis NS, Barzi F, Craig JC. Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study. Pediatr Nephrol 29: 1039-1046, 2014.","DOI":"10.1007\/s00467-013-2736-9"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5811-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:34:15Z","timestamp":1768620855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5811-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5811-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"5811-25"}}